NeoGenomics NEO Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $727.33M+10.1% | $660.57M+11.6% | $591.64M+16.1% | $509.73M+5.2% | ||
| $413.04M+11.5% | $370.47M+6.8% | $347.04M+7.8% | $321.83M+8.3% | ||
| $314.29M+8.3% | $290.1M+18.6% | $244.6M+30.2% | $187.9M+0.4% | ||
| 43.2%-0.7pp | 43.9%+2.6pp | 41.3%+4.5pp | 36.9%-1.8pp | ||
| $37.08M+19.0% | $31.16M+14.1% | $27.31M-9.9% | $30.33M+38.6% | ||
| $92.01M+8.7% | $84.65M+19.5% | $70.84M+5.2% | $67.32M+7.6% | ||
| $273.34M+5.2% | $259.74M+6.8% | $243.1M-0.1% | $243.36M+9.9% | ||
| $430.17M+12.6% | $382.21M+8.5% | $352.34M+2.0% | $345.52M+13.0% | ||
| $430.17M+12.6% | $382.21M+8.5% | $352.34M+2.0% | $345.52M+13.0% | ||
| -$115.88M-25.8% | -$92.11M+14.5% | -$107.74M+31.6% | -$157.62M-32.7% | ||
| -15.9%-2.0pp | -13.9%+4.3pp | -18.2%+12.7pp | -30.9%-6.4pp | ||
| $3.75M-43.3% | $6.62M-4.2% | $6.91M-8.9% | $7.58M-7.8% | ||
| $9.07M-50.8% | $18.43M+9.0% | $16.9M+178% | $6.08M— | ||
| $296K+178% | -$379K-159% | $644K+402% | -$213K+96.1% | ||
| -$110.27M-36.7% | -$80.68M+16.9% | -$97.1M+39.1% | -$159.34M-957% | ||
| -$2.24M-15.1% | -$1.95M+78.7% | -$9.13M+39.5% | -$15.09M-124% | ||
| -$108.03M-37.2% | -$78.73M+10.5% | -$87.97M+39.0% | -$144.25M-1,628% | ||
| -14.9%-2.9pp | -11.9%+3.0pp | -14.9%+13.4pp | -28.3%-26.6pp | ||
| -$0.83-33.9% | -$0.62+11.4% | -$0.70+39.7% | -$1.16-1,557% | ||
| 511.8M+1.1% | 506.1M+0.9% | 501.6M+1.1% | 496.3M+1.3% | ||
| 511.8M+1.1% | 506.1M+0.9% | 501.6M+1.1% | 496.3M+4.1% | ||
| -$0.83-33.9% | -$0.62+11.4% | -$0.7+39.7% | -$1.16-1,557% | ||
| -$0.83-33.9% | -$0.62+11.4% | -$0.7+39.7% | -$1.16-867% | ||
| $27.75M— | $0— | $0— | —— | ||
| $296K+178% | -$379K-159% | $644K+402% | -$213K+96.1% | ||
| -$115.88M-25.8% | -$92.11M+14.5% | -$107.74M+31.6% | -$157.62M-32.7% | ||
| -$48.06M-146% | -$19.56M+44.4% | -$35.15M+60.1% | -$88.19M-34.8% | ||
| -$48.06M-146% | -$19.56M+44.4% | -$35.15M+60.1% | -$88.19M-34.8% | ||
| -6.6%-3.6pp | -3%+3.0pp | -5.9%+11.4pp | -17.3%-3.8pp | ||
| -$115.88M-25.8% | -$92.11M+14.5% | -$107.74M+31.6% | -$157.62M-32.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is NeoGenomics's revenue?
- NeoGenomics (NEO) generated $746.0M in revenue over the trailing twelve months, up 10.9% year over year.
- Is NeoGenomics profitable?
- NeoGenomics is not currently profitable: it reported a net loss of $99.2M over the trailing twelve months, a -13.3% net margin.
- What are NeoGenomics's profit margins?
- Gross margin is 43.2% and operating margin is -14.2%, with a -13.3% net margin.
- What is NeoGenomics's earnings per share?
- NeoGenomics's diluted EPS over the trailing twelve months is $-0.76.
- Where does NeoGenomics's income statement data come from?
- Every line is extracted from NeoGenomics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
